Apollomics (APLM) Current Assets (2021 - 2025)
Apollomics (APLM) posted quarterly Current Assets of $6.1 million for Q4 2025, down 41.06% year-on-year from $10.3 million in Q4 2024, and down 40.26% on a QoQ basis from $10.1 million in Q2 2025.
Apollomics (APLM) Current Assets (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Current Assets for 5 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.
- Quarterly Current Assets fell 41.06% year-over-year to $6.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.1 million (down 41.06% YoY) and the FY2025 annual result came in at $6.1 million, down 41.06% from the prior year.
- Current Assets slipped to $6.1 million in Q4 2025 per APLM's latest filing, from $10.1 million in the prior quarter.
- Over the last five years, Current Assets for APLM reached as high as $99.4 million in Q4 2021 and fell as low as $6.1 million in Q4 2025.
- A 5-year average of $38.2 million and a median of $34.2 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets declined 28.44% — and 2024, when it tumbled 74.28%.
- Year by year, Current Assets stood at $99.4 million in 2021, then plunged by 43.86% to $55.8 million in 2022, then declined by 28.44% to $39.9 million in 2023, then slumped by 74.28% to $10.3 million in 2024, then slumped by 41.06% to $6.1 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $6.1 million, $10.1 million, and $10.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 6.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.05 Mn |
| Jun 30, 2025 | 10.13 Mn |
| Dec 31, 2024 | 10.27 Mn |
| Jun 30, 2024 | 28.41 Mn |
| Dec 31, 2023 | 39.93 Mn |
| Jun 30, 2023 | 55.38 Mn |
| Dec 31, 2022 | 55.79 Mn |
| Dec 31, 2021 | 99.37 Mn |